bf/NASDAQ:IRMD_icon.jpeg

COM:IRADIMED

IRadimed

  • Stock

Last Close

53.23

22/11 21:00

Market Cap

563.05M

Beta: -

Volume Today

41.99K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
11.34M
-
15.65M
38.03%
31.59M
101.84%
32.50M
2.86%
23.08M
28.97%
30.44M
31.88%
38.52M
26.54%
31.72M
17.65%
41.81M
31.83%
53.30M
27.48%
65.56M
23.00%
cost of revenue
2.85M
-
3.40M
19.31%
5.84M
71.55%
6.15M
5.38%
5.57M
9.50%
7.21M
29.48%
8.82M
22.25%
8.14M
7.64%
9.76M
19.92%
12.02M
23.10%
15.40M
28.15%
gross profit
8.49M
-
12.25M
44.33%
25.75M
110.25%
26.34M
2.28%
17.51M
33.52%
23.23M
32.64%
29.70M
27.87%
23.57M
20.63%
32.05M
35.95%
41.28M
28.81%
50.16M
21.50%
selling and marketing expenses
2.30M
-
3.30M
43.52%
4.71M
42.73%
5.28M
12.16%
5.50M
4.25%
7.00M
27.12%
9.17M
31.08%
10.16M
10.79%
10.56M
3.91%
12.68M
20.12%
12.14M
4.24%
general and administrative expenses
2.39M
-
4.82M
101.35%
7.77M
61.30%
8.80M
13.20%
9.00M
2.34%
8.71M
3.22%
10.45M
19.98%
12.27M
17.39%
9.77M
20.36%
10.70M
9.47%
15.12M
41.37%
selling general and administrative expenses
4.69M
-
8.11M
73.02%
12.48M
53.76%
14.07M
12.81%
14.50M
3.06%
15.71M
8.29%
19.62M
24.92%
22.43M
14.31%
20.33M
9.37%
23.38M
15.00%
27.26M
16.63%
research and development expenses
1.01M
-
1.07M
5.82%
1.76M
65.09%
1.35M
23.62%
1.72M
27.83%
1.52M
11.93%
1.43M
5.56%
1.90M
32.79%
1.91M
0.13%
2.28M
19.58%
2.86M
25.49%
other expenses
-3.46K
-
-48.55K
1,303.96%
121.39K
350.03%
32.68K
73.08%
111.38K
240.81%
193.54K
73.77%
395.91K
104.57%
139.21K
64.84%
18.61K
86.64%
553.10K
2,872.88%
cost and expenses
8.55M
-
12.59M
47.17%
20.08M
59.53%
21.58M
7.45%
21.80M
1.02%
24.44M
12.11%
29.87M
22.24%
32.47M
8.72%
32.00M
1.47%
37.68M
17.75%
45.53M
20.84%
operating expenses
5.70M
-
9.18M
61.12%
14.24M
55.07%
15.42M
8.30%
16.23M
5.22%
17.22M
6.14%
21.05M
22.24%
24.33M
15.56%
22.23M
8.62%
25.65M
15.39%
30.12M
17.42%
interest expense
581.85K
-
ebitda
2.93M
-
3.21M
9.87%
11.74M
265.08%
11.17M
4.85%
2.59M
76.78%
7.11M
174.07%
9.89M
39.12%
582.73K
94.11%
11.22M
1,826.18%
15.63M
39.23%
20.04M
28.21%
operating income
2.79M
-
3.07M
10.00%
11.51M
275.52%
10.92M
5.15%
1.29M
88.23%
6.00M
367.22%
8.65M
44.03%
-756.09K
108.74%
9.82M
1,398.48%
15.63M
59.18%
20.04M
28.21%
depreciation and amortization
139.04K
-
149.06K
7.20%
223.94K
50.24%
248.30K
10.88%
1.31M
427.08%
1.11M
15.57%
1.24M
12.43%
1.34M
7.77%
1.41M
5.08%
670.67K
52.33%
total other income expenses net
-3.46K
-
-48.55K
1,303.96%
121.39K
350.03%
32.68K
73.08%
111.38K
240.81%
193.54K
73.77%
395.91K
104.57%
139.21K
64.84%
18.61K
86.64%
553.10K
2,872.88%
1.70M
207.86%
income before tax
2.78M
-
3.02M
8.39%
11.63M
285.59%
10.95M
5.86%
1.40M
87.25%
6.20M
343.81%
9.04M
45.92%
-616.88K
106.82%
9.84M
1,694.53%
16.18M
64.50%
21.74M
34.35%
income tax expense
846.88K
-
966.98K
14.18%
4.10M
324.48%
3.74M
8.93%
896.62K
76.01%
-106.14K
111.84%
-587.64K
453.63%
-1.99M
237.94%
510.82K
125.72%
3.35M
556.47%
4.55M
35.55%
net income
1.94M
-
2.05M
5.86%
7.53M
267.25%
7.21M
4.19%
499.76K
93.07%
6.30M
1,161.29%
9.63M
52.79%
1.37M
85.79%
9.33M
581.19%
12.83M
37.55%
17.19M
34.03%
weighted average shs out
10.42M
-
8.74M
16.06%
11.00M
25.85%
10.82M
1.68%
10.64M
1.66%
10.76M
1.13%
11.28M
4.87%
12.12M
7.46%
12.35M
1.84%
12.56M
1.76%
12.60M
0.32%
weighted average shs out dil
10.42M
-
10.22M
1.89%
12.56M
22.88%
11.99M
4.52%
11.72M
2.25%
12.11M
3.33%
12.28M
1.37%
12.44M
1.33%
12.59M
1.21%
12.64M
0.36%
12.72M
0.69%
eps
0.19
-
0.23
21.05%
0.68
195.65%
0.67
1.47%
0.05
92.54%
0.59
1,080.00%
0.85
44.07%
0.11
87.06%
0.76
590.91%
1.02
34.21%
1.36
33.33%
epsdiluted
0.19
-
0.20
5.26%
0.60
200.00%
0.60
0%
0.04
93.33%
0.52
1,200%
0.78
50%
0.11
85.90%
0.74
572.73%
1.02
37.84%
1.35
32.35%

All numbers in (except ratios and percentages)